首页|青蒿素及其衍生物治疗骨科相关疾病的研究进展

青蒿素及其衍生物治疗骨科相关疾病的研究进展

扫码查看
随着骨科疾病机制研究的不断深入,传统单靶点疗法的弊端日益暴露,寻求多靶点药物已成为目前骨科相关疾病的主流研究方向。青蒿素是从中药青蒿中提取出的倍半萜内酯类化合物,在青蒿素的基础上研究人员逐渐合成了以双氢青蒿素、青蒿琥酯、蒿甲醚、蒿乙醚为代表的多种青蒿素衍生物。近年来药理学研究发现青蒿素及其衍生物能够通过调节成骨-破骨耦联、调节免疫反应、抑制血管生成、保护软骨、抑制肿瘤生长治疗骨质疏松、骨关节炎、类风湿性关节炎、骨肉瘤等骨科相关疾病。该文将对青蒿素及其衍生物的代谢特点和治疗骨科疾病的作用机制进行综述,以期为青蒿素类药物和骨科疾病的现代研究带来启发。
Research progress on artemisinin and its derivatives in treatment of orthopedics-related diseases
As research into the mechanisms of orthopedic diseases continues to deepen,the shortcomings of traditional single-target the-rapies are becoming increasingly apparent.Consequently,the search for multi-target drugs has become the mainstream research direction for orthopedics-related diseases.Artemisinin,a sesquiterpene lactone compound extracted from Artemisia annua,has led to the gradual synthesis of various derivatives such as dihydroartemisinin,artesunate,artemether,and arteether.Recent pharmacological studies have found that artemisinin and its derivatives can treat osteoporosis,osteoarthritis,rheumatoid arthritis,osteosarcoma,and other orthopedic diseases by regulating osteoblast-osteoclast coupling,modulating immune response,inhibiting angiogenesis,protecting cartilage,and in-hibiting tumor growth.This paper reviewed the metabolic characteristics and mechanisms of action of artemisinin and its derivatives in the treatment of orthopedic diseases,aiming to inspire modern research on artemisinin-based drugs and orthopedic diseases.

artemisinindihydroartemisininartesunateosteoporosisarthritisosteosarcoma

封潇添、马剑雄、王岩、申佳慧、周丽芸、李奕扬、孙亚迪、董本超、李岩、杨培川、李光、马天成、崔洪伟、王祺钰、马信龙

展开 >

天津大学天津医院(天津市天津医院),天津 300211

天津市骨科研究所,天津 300050

天津市骨科生物力学与医学工程重点实验室,天津 300050

天津中医药大学中西医结合学院,天津 301617

展开 >

青蒿素 双氢青蒿素 青蒿琥酯 骨质疏松 关节炎 骨肉瘤

国家重点研发计划项目天津市自然科学基金重点项目天津市卫生健康科技项目

2022YFC360190422JCZDJC00340TJWJ2022QN053

2024

中国中药杂志
中国药学会

中国中药杂志

CSTPCD北大核心
影响因子:1.718
ISSN:1001-5302
年,卷(期):2024.49(18)